Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Yuansheng Pharmaceutical is a pharmaceutical company based in Nanchang, China, that focuses on the development and production of active pharmaceutical ingredients (APIs) and finished drug products. The company specializes in antiviral medications, with a product portfolio that includes Ganciclovir, Acyclovir, and Ribavirin. It operates large-scale manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards to ensure high-quality chemical synthesis. In addition to its domestic operations, the company engages in the export of pharmaceutical intermediates to international markets. Jiangxi Yuansheng Pharmaceutical plays a significant role in the regional life sciences sector by providing essential anti-infective treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Yuansheng Pharmaceutical.